These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11526996)

  • 1. Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor.
    Tan EC; Chong SA; Mahendran R; Dong F; Tan CH
    Biol Psychiatry; 2001 Jul; 50(2):144-7. PubMed ID: 11526996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
    Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
    Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis.
    Patsopoulos NA; Ntzani EE; Zintzaras E; Ioannidis JP
    Pharmacogenet Genomics; 2005 Mar; 15(3):151-8. PubMed ID: 15861039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.
    Segman RH; Heresco-Levy U; Finkel B; Inbar R; Neeman T; Schlafman M; Dorevitch A; Yakir A; Lerner A; Goltser T; Shelevoy A; Lerer B
    Psychopharmacology (Berl); 2000 Nov; 152(4):408-13. PubMed ID: 11140333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D3 receptor variant and tardive dyskinesia.
    Rietschel M; Krauss H; Müller DJ; Schulze TG; Knapp M; Marwinski K; Maroldt AO; Paus S; Grünhage F; Propping P; Maier W; Held T; Nöthen MM
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(1):31-5. PubMed ID: 10738862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
    Gunes A; Scordo MG; Jaanson P; Dahl ML
    Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
    Peñas-Lledó EM; Dorado P; Cáceres MC; de la Rubia A; Llerena A
    Clin Chem Lab Med; 2007; 45(7):835-8. PubMed ID: 17617023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene.
    Herken H; Erdal ME; Böke O; Savaş HA
    Eur Psychiatry; 2003 Mar; 18(2):77-81. PubMed ID: 12711403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia.
    Zhang ZJ; Zhang XB; Sha WW; Zhang XB; Reynolds GP
    Mol Psychiatry; 2002; 7(7):670-1. PubMed ID: 12192608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
    Gałecki P; Pietras T; Szemraj J
    Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.
    Lerer B; Segman RH; Tan EC; Basile VS; Cavallaro R; Aschauer HN; Strous R; Chong SA; Heresco-Levy U; Verga M; Scharfetter J; Meltzer HY; Kennedy JL; Macciardi F
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):411-25. PubMed ID: 15857569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia.
    Eichhammer P; Albus M; Borrmann-Hassenbach M; Schoeler A; Putzhammer A; Frick U; Klein HE; Rohrmeier T
    Am J Med Genet; 2000 Apr; 96(2):187-91. PubMed ID: 10893495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms.
    Güzey C; Scordo MG; Spina E; Landsem VM; Spigset O
    Eur J Clin Pharmacol; 2007 Mar; 63(3):233-41. PubMed ID: 17225991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative association between T102C polymorphism of the 5-HT2a receptor gene and schizophrenia in Japan.
    Shinkai T; Ohmori O; Kojima H; Terao T; Suzuki T; Abe K
    Hum Hered; 1998; 48(4):212-5. PubMed ID: 9694252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach.
    Anttila S; Kampman O; Illi A; Rontu R; Lehtimäki T; Leinonen E
    BMC Psychiatry; 2007 May; 7():22. PubMed ID: 17521439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group.
    Williams J; Spurlock G; McGuffin P; Mallet J; Nöthen MM; Gill M; Aschauer H; Nylander PO; Macciardi F; Owen MJ
    Lancet; 1996 May; 347(9011):1294-6. PubMed ID: 8622505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6.
    Ellingrod VL; Schultz SK; Arndt S
    Pharmacotherapy; 2002 Nov; 22(11):1416-9. PubMed ID: 12432967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T102C polymorphisms at the 5-HT2A receptor gene in Turkish schizophrenia patients: a possible association with prognosis.
    Herken H; Erdal ME; Erdal N; Aynacioglu S
    Neuropsychobiology; 2003; 47(1):27-30. PubMed ID: 12606842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.